Decreased emergence of HIV-1 drug resistance mutations in a cohort of Ugandan women initiating option B+ for PMTCT

Simple item page
dc.contributor.authorMachnowska, Patrycja
dc.contributor.authorBusingye, Priscilla
dc.contributor.authorRubaihayo, John
dc.contributor.authorTheuring, Stefanie
dc.date.accessioned2025-05-07T19:47:06Z
dc.date.available2025-05-07T19:47:06Z
dc.date.issued2017-05-31
dc.description.abstractSince 2012, WHO guidelines for the prevention of mother-to-child transmission (PMTCT) of HIV-1 in resource-limited settings recommend the initiation of lifelong antiretroviral combination therapy (cART) for all pregnant HIV-1 positive women independent of CD4 count and WHO clinical stage (Option B+). However, long-term outcomes regarding development of drug resistance are lacking until now. Therefore, we analysed the emergence of drug resistance mutations (DRMs) in women initiating Option B+ in Fort Portal, Uganda, at 12 and 18 months postpartum (ppm).
dc.identifier.citationMachnowska, P., Hauser, A., Meixenberger, K., Altmann, B., Bannert, N., Rempis, E., ... & Theuring, S. (2017). Decreased emergence of HIV-1 drug resistance mutations in a cohort of Ugandan women initiating option B+ for PMTCT. PLoS One, 12(5), e0178297.
dc.identifier.otherhttps://doi.org/10.1371/journal.pone.0178297
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/11497
dc.language.isoen
dc.publisherPLoS One
dc.titleDecreased emergence of HIV-1 drug resistance mutations in a cohort of Ugandan women initiating option B+ for PMTCT
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
file (7).pdf
Size:
1.01 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences